Spinal muscular atrophy type 1 in the Caribbean: the first case report from the Dominican Republic
Spinal muscular atrophy (SMA) is a progressive genetic neuromuscular condition affecting spinal motor neurons. The underlying cause of SMA is deletions or mutations in the SMN gene. It is classified into five variants based on age and clinical manifestations of the patient. In this report, we presen...
Saved in:
| Main Authors: | María Belén Martín-Sanz, Delvis Lucas-Muñoz, Manuel Colomé-Hidalgo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2024.1476977/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and preliminary safety assessment of EXG001-307 AAV gene therapy for spinal muscular atrophy
by: Chunjuan Song, et al.
Published: (2025-06-01) -
The Life-Saving Impact of Early Diagnosis and Treatment for Spinal Muscular Atrophy Type 1
by: Almas Siddique, et al.
Published: (2025-04-01) -
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds
by: Jonathan J. Cherry, et al.
Published: (2013-06-01) -
Insights into diagnostic difficulties in spinal muscular atrophy: a Case Report series
by: Kakha Bregvadze, et al.
Published: (2024-12-01) -
Adult spinal muscular atrophy: problems of early diagnosis
by: Yu. A. Shpilyukova, et al.
Published: (2022-12-01)